Iron Deficiency in IBD: Ferritin and Transferrin Saturation
By the Aidy Editorial Team
First Published Jun 28, 2026Last Updated Jul 23, 2026
Fatigue is one of the most common and most frustrating parts of living with inflammatory bowel disease, and iron deficiency is one of its most treatable causes. Anemia is described as one of the most common extraintestinal manifestations of IBD, affecting roughly 27% of people with Crohn's disease and 21% of those with ulcerative colitis. Yet many people are told their bloodwork looks normal while they still feel exhausted. The reason often lies in which numbers were measured and how they were interpreted. This article explains how iron deficiency in IBD shows up on labs, why hemoglobin can look normal even when your iron stores are empty, and what ferritin and transferrin saturation add to the picture.
Why hemoglobin can look normal while iron runs low
Hemoglobin is the protein in red blood cells that carries oxygen, and it is the number most people check first. The World Health Organization defines anemia as hemoglobin below 13 g/dL in men and below 12 g/dL in non-pregnant women. The problem is that hemoglobin is a late marker. The body draws down its stored iron first, and only after those reserves are exhausted does red blood cell production fall enough to lower hemoglobin. Iron deficiency can therefore be present, and can cause symptoms, well before anemia appears. The Crohn's & Colitis Foundation anemia care pathway recognizes this non-anemic iron deficiency, defining inadequate stores by ferritin even when hemoglobin sits in range. A normal hemoglobin rules out overt anemia, yet it does not rule out low iron with normal hemoglobin, and it says little about how tired you may feel.
Ferritin, the storage marker that inflammation distorts
Ferritin reflects how much iron your body holds in reserve, which makes it the single most useful test for iron deficiency. In someone without inflammation, a serum ferritin below 30 µg/L is an accepted criterion for iron deficiency. In IBD the interpretation is harder because ferritin is an acute-phase protein made by the liver that rises during inflammation regardless of iron stores. Active Crohn's or colitis can push ferritin up and mask a genuine deficiency. To account for this, ECCO guidance states that when inflammation is present, a serum ferritin up to 100 µg/L may still be consistent with iron deficiency. That is why ferritin should be read alongside a marker of inflammation. AGA biomarker guidance for Crohn's disease treats C-reactive protein below 5 mg/L as evidence against active inflammation and higher values as a sign of active disease. A ferritin of 60 means very different things at a C-reactive protein of 2 versus 40.
What transferrin saturation adds
When ferritin is ambiguous, transferrin saturation helps. Transferrin is the protein that transports iron in the blood, and transferrin saturation is the percentage of it currently carrying iron. The normal range is roughly 20 to 45%, and a value below 20% points to iron that is not adequately available for making red blood cells. In IBD this can happen for two overlapping reasons. In true iron deficiency the tank is empty. In anemia of chronic disease, inflammation drives a hormone called hepcidin that traps iron inside storage cells, so transferrin saturation falls even when ferritin reads normal or high. These two mechanisms frequently coexist in IBD. For ulcerative colitis, AGA guidance similarly relies on C-reactive protein and fecal calprotectin to judge whether inflammation is active. Reading ferritin, transferrin saturation, and an inflammatory marker together is what separates true iron deficiency from inflammation-driven changes.
Oral versus intravenous iron
Once iron deficiency is confirmed, the route of replacement matters more in IBD than in the general population. Oral iron is inexpensive but often poorly tolerated and poorly absorbed here. Inflammation raises hepcidin, which degrades the ferroportin channel that moves iron out of the gut lining, so much of an oral dose is never absorbed, and the unabsorbed iron can worsen gastrointestinal symptoms. For these reasons ECCO recommends intravenous iron as first-line treatment for patients with clinically active IBD, previous intolerance to oral iron, or hemoglobin below 10 g/dL. Modern intravenous formulations such as ferric carboxymaltose allow large replacement doses in one or two visits with a favorable side-effect profile. Oral iron is reserved for people with mild anemia whose disease is quiet and who tolerate it.
How to track iron labs over time
Iron status in IBD is a moving target because it rises and falls with disease activity, bleeding, and treatment, so a single snapshot tells you less than a trend. The Crohn's & Colitis Foundation pathway recommends ferritin as a universal screening test and stresses recognizing the link between fatigue and anemia. ECCO guidance suggests rechecking iron studies every 6 to 12 months in patients in remission or with mild disease, and more often during active disease or after starting treatment. Keeping ferritin, transferrin saturation, hemoglobin, and C-reactive protein in one place, alongside notes on fatigue, visible bleeding, and any supplements, lets you and your care team see whether a low ferritin is a one-time dip or a pattern that needs intravenous replacement.
What the numbers mean together
No single value tells the whole story of iron deficiency in IBD. Hemoglobin confirms anemia but misses the deficiency that comes before it. Ferritin measures stores yet is inflated by inflammation, so it has to be paired with C-reactive protein and read against a higher cutoff during flares. Transferrin saturation below 20% signals that iron is not reaching the bone marrow, whether because stores are empty or because inflammation is holding iron in reserve. Anemia carries a real burden, contributing to the fatigue that affects most people with active IBD, and it responds well to treatment once it is correctly identified. Understanding these labs, and watching how they move over time, turns a confusing panel of results into a clear picture of whether your iron needs attention.
This article is for educational purposes and is not medical advice. It is researched against current AGA clinical guidelines and peer-reviewed sources. Always discuss treatment decisions with your care team.